LHC Group Stock Rating Upgraded by Zacks (LHCG)
LHC Group (NASDAQ:LHCG) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a note issued to investors on Monday. The firm currently has a $26.40 price target on the stock. Zacks‘s target price would suggest a potential upside of 9.41% from the stock’s previous close.
LHC Group (NASDAQ:LHCG) traded up 1.45% during mid-day trading on Monday, hitting $24.48. 25,494 shares of the company’s stock traded hands. LHC Group has a 52 week low of $19.69 and a 52 week high of $26.43. The stock’s 50-day moving average is $21.96 and its 200-day moving average is $21.94. The company has a market cap of $435.5 million and a P/E ratio of 20.45.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.32 by $0.03. The company had revenue of $188.90 million for the quarter, compared to the consensus estimate of $179.90 million. During the same quarter last year, the company posted $0.34 earnings per share. LHC Group’s revenue was up 13.6% compared to the same quarter last year. On average, analysts predict that LHC Group will post $1.23 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Piper Jaffray raised their price target on shares of LHC Group from $25.00 to $28.00 in a research note on Monday. Analysts at Oppenheimer reiterated an “outperform” rating on shares of LHC Group in a research note on Friday. They now have a $27.00 price target on the stock, up previously from $26.00. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $24.90.
LHC Group, Inc (NASDAQ:LHCG) provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs).
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.